A randomized, double-blind, placebo-controlled trial of infliximab in refractory polymyositis and dermatomyositis-Reference-Cited by-同舟云学术

A randomized, double-blind, placebo-controlled trial of infliximab in refractory polymyositis and dermatomyositis

Published:2018-06 Issue:6 Volume:47 Page:858-864
ISSN:0049-0172
Container-title:Seminars in Arthritis and Rheumatism
language:en
Short-container-title:Seminars in Arthritis and Rheumatism

Author:

Schiffenbauer Adam,Garg Megha,Castro Christine,Pokrovnichka Angelina,Joe Galen,Shrader Joseph,Cabalar Imelda Victoria,Faghihi-Kashani Sara,Harris-Love Michael O.,Plotz Paul H.,Miller Frederick W.,Gourley Mark

Publisher

Elsevier BV

Subject

Anesthesiology and Pain Medicine,Rheumatology

Reference40 articles.

1. Effect of tumor necrosis factor-alpha on skeletal muscle metabolism;Li;Curr Opin Rheumatol,2001

2. Novel approaches in the treatment of myositis and myopathies;Albayda;Ther Adv Musculoskelet Dis,2012

3. Therapeutic advances in myositis;Aggarwal;Curr Opin Rheumatol,2012

4. Tumor necrosis factor-alpha in inflammatory myopathies: pathophysiology and therapeutic implications;Efthimiou;Semin Arthritis Rheum,2006

5. A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies;Dastmalchi;Ann Rheum Dis,2008

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Paradoxical and bimodal immune‐mediated dermatological side effects of TNF‐α inhibitors: A comprehensive review;Skin Research and Technology;2024-05

2. Where are we now in biologic drugs for myositis?;Rheumatology;2024-02-06

3. Local injection of infliximab into calcinosis lesions in patients with juvenile dermatomyositis (JDM): a clinical trial;Pediatric Rheumatology;2024-01-02

4. Idiopathic Inflammatory Myositis;Neuroimmune Diseases;2024

5. Skin involvement in other autoimmune diseases;The Rose and Mackay Textbook of Autoimmune Diseases;2024